News & Updates

Patients with hypertension appear to have lower overall perceived health compared with normotensive individuals, but those who engage in high levels of leisure-time physical activity are more likely to rate their health status as ‘very good’ or ‘excellent’, as reported in a study.

A recent real-world study has confirmed that the HeartMate 3 (HM3) device has good postapproval performance, yielding a 6-month survival rate that was comparable to its trial results.

Adding alirocumab to rosuvastatin led to a significantly reduced coronary plaque in noninfarct-related arteries in patients with acute myocardial infarction (MI), according to the PACMAN-AMI* trial presented at ACC 2022.

Light-to-moderate consumption of alcoholic beverages has been touted as beneficial for heart health. But a large study says otherwise, revealing that alcohol consumption in whatever amount carries increased cardiovascular risk and that its supposed benefits appear to be the upshot of favourable lifestyle factors common among light-to-moderate drinkers.

Intensive blood pressure (BP) treatment to reduce BP below 120/80 mm Hg appears to protect against the risk of intracranial haemorrhage (ICH) but not that of ischaemic stroke when compared with standard BP treatment among patients with a history of cerebral infarction, according to a post hoc analysis of RESPECT.